Numerous studies have shown abnormal MFAP2 levels and its effects on prognosis in different cancers (Table 1), highlighting its significance in tumor progression, particularly during epithelial-mesenchymal transformation (EMT), because of its association with TGF-β (24, 31, 32). This evidence concerns the gene MFAP2 and neoplasm.